文献速递耳科与耳神经

患者合并症如何影响成人人工耳蜗植入结局

How do Patient Comorbidities Influence Adult Cochlear Implant Outcomes?
PubMed 文献 · Otolaryngol Head Neck Surg · 2026-01-31

这项回顾性队列研究纳入2017至2022年接受人工耳蜗植入的346例双侧听力损失成人,计算Charlson指数、Elixhauser指数和基础求和指数,评估其与术后言语识别及患者报告结局的关系。结果显示Charlson指数与早期和长期言语识别负相关,Elixhauser指数独立预测早期和长期AzBioQ,但各指数均与PROMs无关。

要点

  • Charlson指数与人工耳蜗术后早期和长期言语识别负相关。
  • Elixhauser指数独立预测早期和长期AzBioQ评分。
  • 合并症负担与患者报告结局无显著关联。

核心结论

  • 累积合并症负担影响人工耳蜗植入后的言语识别表现。
  • 不同合并症指数对人工耳蜗结局的影响存在差异。

研究设计与样本

  • 回顾性队列研究,纳入2017至2022年接受人工耳蜗植入的346例双侧听力损失成人。
  • 通过麻醉记录、用药清单和临床就诊记录提取合并症,计算Charlson指数、Elixhauser指数和基础求和指数。

主要发现

  • Charlson指数与早期和长期CNC及AzBioQ均呈负相关(rs = -0.16至-0.31,所有FDR校正P < .05)。
  • Elixhauser指数与早期AzBioQ负相关(rs = -0.22)。
  • 基础求和指数与早期CNC和长期AzBioQ负相关。
  • 多变量模型中仅Elixhauser指数独立预测早期AzBioQ(β = -1.03,P = .005)和长期AzBioQ(β = -0.65,P = .050)。
  • 各合并症指数均与患者报告结局无关联。

临床怎么用

  • 临床可利用合并症指数评估成人人工耳蜗植入术后言语识别预后的潜在风险。
  • Elixhauser指数或有助于识别早期和长期AzBioQ表现较差的患者。

局限性

  • 回顾性研究设计。
  • 单中心三级神经耳科中心数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the relationship between weighted comorbidity indices and post-cochlear implant (CI) speech recognition and patient-reported outcome measures (PROMs). STUDY DESIGN: Retrospective cohort. SETTING: Tertiary Neurotology Center. METHODS: Adults with bilateral hearing loss who received CIs from 2017 to 2022 were included. Comorbidities were extracted via chart review of anesthesia notes, medication lists, and clinical encounters. Three comorbidity scores were calculated: the Charlson Index (10-year mortality), Elixhauser Index (30-day hospital readmission), and a basic sum index assigning equal weight to 31 conditions. Spearman correlations evaluated bivariate associations. Multivariable linear regression was used to evaluate independent contributions of each index to CI outcomes, adjusting for clinical covariates. Early (1- or 3-month post-CI) and long-term (6- or 12-month post-CI) outcomes included Consonant-Nucleus-Consonant word recognition (CNC) and AzBio sentence recognition in quiet (AzBioQ), and PROMs. RESULTS: 346 patients were included. The Charlson Index was negatively associated with both early and long-term speech recognition outcomes (CNC and AzBioQ; rs = -0.16 to -0.31, all FDR-adjusted P < .05). The Elixhauser Index negatively correlated with early AzBioQ scores (rs = -0.22), while the basic sum index negatively correlated with early CNC and long-term AzBioQ. No indices were associated with PROMs. In multivariable models, only the Elixhauser Index independently predicted early (β = -1.03, P = .005) and long-term (β = -0.65, P = .050) AzBioQ. CONCLUSION: Our findings highlight the influence of cumulative comorbid disease burden on speech recognition performance and suggests a differential impact of individual comorbidities on CI outcomes.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Spector B, Nguyen T, Bandaru P, et al. How do Patient Comorbidities Influence Adult Cochlear Implant Outcomes? Otolaryngol Head Neck Surg. 2026. PMID: 41618831. doi:10.1002/ohn.70082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。